The Evolution of Severe Steatosis After Bariatric Surgery Is Related to Insulin Resistance

Gastroenterology

Volumn 130, Issue 6, 2006, Pages 1617-1624

  Mathurin, Philippe ^a,b   Gonzalez, Florent ^a,b   Kerdraon, Olivier ^a   Leteurtre, Emmanuelle ^a   Arnalsteen, Laurent ^a,b   Hollebecque, Antoine ^a,b   Louvet, Alexandre ^a,b   Dharancy, Sébastien ^a,b   Cocq, Perrine ^a   Jany, Thomas ^a   Boitard, Jeanne ^a   Deltenre, Pierre ^a   Romon, Monique ^a   Pattou, François ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY FAT; BODY MASS; DISEASE SEVERITY; EVOLUTION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER BIOPSY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; STEATOSIS;

EID: 33646346335     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.02.024     Document Type: Article

References (58)

1. Keller K.B., and Lemberg L. Obesity and the metabolic syndrome. J Crit Care 12 (2003) 167-170
2. Neuschwander-Tetri B.A., and Caldwell S.H. Nonalcoholic steatohepatitis. summary of an AASLD single topic conference. Hepatology 37 (2003) 1202-1219
3. Wanless I., and Lentz J. Fatty liver hepatitis (steatohepatitis) and obesity. an autopsy study with analysis of risk factors. Hepatology 12 (1990) 1106-1110
4. Lee R.G. Nonalcoholic steatohepatitis. a study of 49 patients. Hum Pathol 20 (1989) 594-598
5. Teli M.R., James O.F., Burt A.D., Bennett M.K., and Day C.P. The natural history of nonalcoholic fatty liver. a follow-up study. Hepatology 22 (1995) 1714-1719
6. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., and Powell L.W. The natural history of nonalcoholic steatohepatitis. a follow-up study of forty-two patients for up to 21 years. Hepatology 11 (1990) 74-80
7. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., Khalil L., Turpin G., Opolon P., and Poynard T. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
8. Bacon B.R., Farahvash M.J., Janney C.G., and Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis. an expanded clinical entity. Gastroenterology 107 (1994) 1103-1109
9. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., and McCullough A.J. Nonalcoholic fatty liver disease. a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
10. Harrison S.A., Torgerson S., and Hayashi P.H. The natural history of nonalcoholic fatty liver disease. a clinical histopathological study. Am J Gastroenterol 98 (2003) 2042-2047
11. Adams L.A., Sanderson S., Lindor K.D., and Angulo P. The histological course of nonalcoholic fatty liver disease. a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42 (2005) 132-138
12. Day C.P., and James O.F. Steatohepatitis. a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
13. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114 (2004) 147-152
14. Day C.P., and James O.F.W. Hepatic steatosis. innocent bystander or guilty party?. Hepatology 27 (1998) 1463-1466
15. Sorensen T.I., Orholm M., Bentsen K.D., Hoybye G., Eghoje K., and Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 2 (1984) 241-244
16. Teli M.R., Day C.P., Burt A.D., Benett M.K., and James O.F. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346 (1995) 987-990
17. Fartoux L., Chazouilleres O., Wendum D., Poupon R., and Serfaty L. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 41 (2004) 82-87
18. Castera L., Hezode C., Roudot-Thoraval F., Bastie A., Zafrani E.S., Pawlotsky J.M., and Dhumeaux D. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients. Gut 52 (2003) 288-292
19. Reeves H.L., Burt A.D., Wood S., and Day C.P. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol 25 (1996) 677-683
20. Kral J.G., Sjostrom L.V., and Sullivan M.B. Assessment of quality of life before and after surgery for severe obesity. Am J Clin Nutr 55 Suppl (1992) 611S-614S
21. O'Brien P.E., Dixon J.B., Brown W., Schachter L.M., Chapman L., Burn A.J., Dixon M.E., Scheinkestel C., Halket C., Sutherland L.J., Korin A., and Baquie P. The laparoscopic adjustable gastric band (Lap-Band). a prospective study of medium-term effects on weight, health and quality of life. Obes Surg 12 (2002) 652-660
22. Sjostrom C.D., Lissner L., Wedel H., and Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery. the SOS Intervention Study. Obes Res 7 (1999) 477-484
23. Torgerson J.S., and The "Swedish Obese Subjects" (SOS) Study. What does weight loss really accomplish?. Fortschr Med 144 (2002) 24-26
24. Angrisani L., Furbetta F., Doldi S.B., Basso N., Lucchese M., Giacomelli F., Zappa M., Di Cosmo L., Veneziani A., Turicchia G.U., Alkilani M., Forestieri P., Lesti G., Puglisi F., Toppino M., Campanile F., Capizzi F.D., D'Atri C., Sciptoni L., Giardiello C., Di Lorenzo N., Lacitignola S., Belvederesi N., Marzano B., Bernate P., Iuppa A., Borrelli V., and Lorenzo M. Lap Band adjustable gastric banding system. the Italian experience with 1863 patients operated on 6 years. Surg Endosc 17 (2003) 409-412
25. Sorensen T.I. Weight loss causes increased mortality. pros. Obes Rev 4 (2003) 3-7
26. Yang D., Fontaine K.R., Wang C., and Allison D.B. Weight loss causes increased mortality. cons. Obes Rev 4 (2003) 9-16
27. Fisher B.L., and Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg 184 (2002) 9S-16S
28. Baddeley R.M. An epilogue to jejunoileal bypass. World J Surg 9 (1985) 842-849
29. Dean P., Joshi S., and Kaminski D.L. Long-term outcome of reversal of small intestinal bypass operations. Am J Surg 118 (1990) 118-123
30. Hocking M.P., Duerson M.C., O'Leary J.P., and Woodward E.R. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med 308 (1983) 995-999
31. Iber F.L., and Copper M. Jejunoileal bypass for the treatment of massive obesity. Prevalence, morbidity, and short- and long-term consequences. Am J Clin Nutr 30 (1977) 4-15
32. McFarland R.J., Gazet J.C., and Pilkington T.R. A 13-year review of jejunoileal bypass. Br J Surg 72 (1985) 81-87
33. Organ Jr. C.H., Kessler E., and Lane M. Long-term results of jejunoileal bypass in the young. Am Surg 50 (1984) 589-593
34. Requarth J.A., Burchard K.W., Colacchio T.A., Stukel T.A., Mott L.A., Greenberg E.R., and Weismann R.E. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal. Arch Surg 130 (1995) 318-325
35. Castillo J., Fabrega E., Escalante C.F., Sanjuan J.C., Herrera L., Hernanz F., Martino E., Casafont F., and Gomez Fleitas M. Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbid obesity. Obes Surg 11 (2001) 640-642
36. Grimm I.S., Schindler W., and Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am J Gastroenterol 87 (1992) 775-779
37. Hamilton D.L., Vest T.K., Brown B.S., Shah A.N., Menguy R.B., and Chey W.Y. Liver injury with alcoholic like hyalin after gastroplasty for morbid obesity. Gastroenterology 85 (1983) 722-726
38. Dixon J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease. predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001) 91-100
39. Dixon J.B., Bhathal P.S., Hughes N.R., and O'Brien P.E. Nonalcoholic fatty liver disease. improvement in liver histological analysis with weight loss. Hepatology 39 (2004) 1647-1654
40. Eriksson F. Biliointestinal bypass. Int J Obes 5 (1981) 437-447
41. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., and Quon M.J. Quantitative insulin sensitivity check index. a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
42. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
43. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis. a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
44. Silverman J.F., O'Brien K.F., Long S., Leggett N., Khazanie P.G., Pories W.J., Norris H.T., and Caro J.F. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 85 (1990) 1349-1355
45. Sanyal A.J., Campbell-Sargent C., Mirshahi F., Rizzo W.B., Contos M.J., Sterling R.K., Luketic V.A., Shiffman M.L., and Clore J.N. Nonalcoholic steatohepatitis. association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120 (2001) 1183-1192
46. Samuel V.T., Liu Z.X., Qu X., Elder B.D., Bilz S., Befroy D., Romanelli A.J., and Shulman G.I. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279 (2004) 32345-32353
47. Kim J.K., Fillmore J.J., Chen Y., Yu C., Moore I.K., Pypaert M., Lutz E.P., Kako Y., Velez-Carrasco W., Goldberg I.J., Breslow J.L., and Shulman G.I. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 98 (2001) 7522-7527
48. Hilden M., Juhl E., Thomsen A.C., and Christoffersen P. Fatty liver persisting for up to 33 years. A follow-up of the inversen-roholm liver biopsy material. Acta Med Scand 194 (1973) 485-489
49. Angelico F., Del Ben M., Conti R., Francioso S., Feole K., Fiorello S., Cavallo M.G., Zalunardo B., Lirussi F., Alessandri C., and Violi F. Insulin resistance, the metabolic syndrome, and nonalcoholic liver disease. J Clin Endocrinol Metab 90 (2005) 1578-1582
50. Comert B., Mas M.R., Erdem H., Dinc A., Saglamkaya U., Cigerim M., Kuzhan O., Unal T., and Kocabalkan F. Insulin resistance in non-alcoholic steatohepatitis. Dig Liver Dis 33 (2001) 353-358
51. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A.J., Natale S., Forlani G., and Melchionda N. Nonalcoholic fatty liver disease. a feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
52. Chitturi S., Abeygunasekera S., Farrell G.C., Holmes-Walker J., Hui J.M., Fung C., Karim R., Lin R., Samarasinghe D., Liddle C., Weltman M., and George J. NASH and insulin resistance. insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
53. Lee J.H., Rhee P.L., Lee J.K., Lee K.T., Kim J.J., Koh K.C., Paik S.W., Rhee J.C., and Choi K.W. Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. Korean J Intern Med 13 (1998) 12-14
54. Pagano G., Pacin G., Musso G., Gambino R., Mecca F., Depetris N., Cassader M., David E., Cavallo-Perin P., and Rizzetto M. Non alcoholic steatohepatitis, insulin resistance, and metabolic syndrome. further evidence for an etiologic association. Hepatology 35 (2002) 367-372
55. Ludwig J., Viggiano T.R., McGill D.B., and Oh B.J. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 (1980) 434-438
56. Byron D., and Minuk G.Y. Clinical hepatology. profile of an urban, hospital-based practice. Hepatology 24 (1996) 813-815
57. Daniel S., Ben-Menachem T., Vasudevan G., Ma C.K., and Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 94 (1999) 3010-3014
58. Adams L.A., Lym J.F., St Sauver J., Sanderson S.O., Lindor K.D., Feldstein A., and Angulo P. The natural history of nonalcoholic fatty liver disease. a population-based cohort study. Gastroenterology 129 (2005) 113-121